A detailed history of Squarepoint Ops LLC transactions in Meira G Tx Holdings PLC stock. As of the latest transaction made, Squarepoint Ops LLC holds 29,249 shares of MGTX stock, worth $124,600. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,249
Holding current value
$124,600
% of portfolio
0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$4.21 - $5.81 $123,138 - $169,936
29,249 New
29,249 $123,000
Q4 2023

Feb 14, 2024

BUY
$3.6 - $7.15 $139,874 - $277,806
38,854 New
38,854 $272,000
Q3 2022

Nov 14, 2022

BUY
$7.55 - $11.25 $42,159 - $62,820
5,584 Added 42.45%
18,739 $158,000
Q2 2022

Aug 15, 2022

BUY
$6.8 - $14.23 $89,454 - $187,195
13,155 New
13,155 $100,000
Q2 2021

Aug 16, 2021

SELL
$12.85 - $16.2 $304,930 - $384,426
-23,730 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$13.84 - $17.8 $138,164 - $177,697
9,983 Added 72.62%
23,730 $342,000
Q4 2020

Feb 16, 2021

BUY
$12.4 - $17.6 $170,462 - $241,947
13,747 New
13,747 $208,000
Q2 2020

Aug 14, 2020

SELL
$11.79 - $15.97 $344,562 - $466,723
-29,225 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$9.31 - $21.24 $671,567 - $1.53 Million
-72,134 Reduced 71.17%
29,225 $393,000
Q4 2019

Feb 14, 2020

BUY
$13.91 - $21.48 $580,533 - $896,467
41,735 Added 70.0%
101,359 $2.03 Million
Q3 2019

Nov 14, 2019

BUY
$15.84 - $30.01 $641,900 - $1.22 Million
40,524 Added 212.17%
59,624 $951,000
Q2 2019

Aug 14, 2019

BUY
$17.38 - $26.88 $331,958 - $513,408
19,100 New
19,100 $513,000
Q3 2018

Nov 14, 2018

SELL
$8.1 - $13.6 $119,880 - $201,280
-14,800 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$11.2 - $15.0 $165,760 - $222,000
14,800 New
14,800 $170,000

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $192M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.